https://www.taxtmi.com/caselaws?id=50805 The Tribunal concluded that prednisolone tablets of 10 mg and 20 mg strength should be classified under heading 3003.20 as a medicament, overturning the initial classification under sub-heading 10 of heading 30.03 as a patent or proprietary medicament. The Tribunal found that the presence of the manufacturer's name alone on the tablets was insufficient to establish a relationship between the medicine and the manufacturer, ultimately allowing the appeals and setting aside the impugned order without addressing the extended period invoked in the show cause notice. en-us Thu, 04 Oct 2001 00:00:00 +0530 Wed, 08 Sep 2010 16:56:53 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=50805 The Tribunal concluded that prednisolone tablets of 10 mg and 20 mg strength should be classified under heading 3003.20 as a medicament, overturning the initial classification under sub-heading 10 of heading 30.03 as a patent or proprietary medicament. The Tribunal found that the presence of the manufacturer's name alone on the tablets was insufficient to establish a relationship between the medicine and the manufacturer, ultimately allowing the appeals and setting aside the impugned order without addressing the extended period invoked in the show cause notice. Case-Laws Central Excise Thu, 04 Oct 2001 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=50805